SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC
http://www.w3.org/2000/01/rdf-schema#comment
"Tissue kallikrein decreased GSK-3beta activity via the phosphatidylinositol 3-kinase-Akt pathway and enhanced VEGF and VEGFR-2 expression in endothelial cells."
xsd:string
http://purl.uniprot.org/uniprot/#_44C4BC82B948D8698FFA351CB6169A225AC1E4FC86DFBCD8B038EBB01989E1FF263E4D6FB8C227B8D2DCF1AC9215C3C5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC
http://purl.uniprot.org/uniprot/A0A1R3UCD2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC
http://purl.uniprot.org/uniprot/#_A0A1R3UCD2-mappedCitation-18689794
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/89B3BCF646D0AC33A34946527DAEA47CC49F75DF151A106FCCBF8DB0F42A902514334E6CA4C9A127295AA68ED5D850AC